13 September 2026: Glochem Industries Private Limited has appointed Swarup Datta as its new Vice President – Head R&D, CDMO. In this role, he will manage the company’s research and development operations as it strengthens its integrated contract development and manufacturing organization (CDMO) and active pharmaceutical ingredient (API) manufacturing platform.

In this capacity, Swarup will oversee CDMO R&D, process development, technology transfer, and commercial manufacturing. His mandate includes developing scalable, cost-effective chemical solutions and managing cross-functional technical teams as the organization integrates the complementary capabilities of Glochem Industries, Chieron Active Ingredients, and Maksons’ Fine Chem.

He brings more than two decades of experience across pharmaceutical R&D, process chemistry, and API development. Prior to joining Glochem, he served as Associate Director at Piramal Pharma Ltd. Earlier, he held the position of Associate Director at Aragen Life Sciences, focusing on process research and development for early- and late-phase molecules. His industry career also includes roles as Senior Principal Scientist and Deputy General Manager at Glenmark Life Sciences, Principal Investigator at Syngene International Limited, and Senior Research Scientist at Daiichi Sankyo Life Sciences Research Centre India.

By combining deep scientific expertise with business administration, his leadership will center on advancing process innovation, strengthening technical governance, and supporting Glochem’s commercial manufacturing objectives for global clients.

Curated by SSF Global

Tracking the shifts shaping GCCs, enterprise ecosystems, and the future of global business.

Share on